Read the full article here.
This content was originally published by the new yorker business. Original publishers retain all rights. It appears here for a limited time before automated archiving. By the new yorker business
New “living drugs”—made from a patient’s own cells—can cure once incurable cancers, Siddhartha Mukherjee writes. But can we afford them?